A Study of CS231295 in Patients With Advanced Solid Tumors
A Study of CS231295 in Patients With Advanced Solid Tumors
Not yet recruiting · NCT07612488 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of CS231295 in Patients With Advanced Solid Tumors | neoplasm | Not yet recruiting | Phase 1 | 2026-05-28 | NCT07612488 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ThalassaX Therapeutics United States Ltd | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Florida Cancer Specialists | Sarasota | United States | 47 |
| Sarah Cannon Research Institute at HealthOne | Denver | United States | 34 |
| Scri Oncology Partners | Nashville | United States | 156 |